Objectives: Type 1 diabetes (T1D) is primarily characterised by the autoimmune destruction of pancreatic beta cells, leading to insulin deficiency. In T1D, there is evidence of a loss of sympathetic nerve fibres in the pancreas, which disrupts normal neurotransmitter signalling. Neuronal loss can increase systemic norepinephrine levels, contributing to sympathetic nervous system hyperactivity. Investigating the interplay between the immune and sympathetic nervous systems could unveil new insights into how these factors contribute to the onset and progression of T1D. Material and Methods: This study used biomarker analyses and gene-expression datasets to identify potential intervention points and elucidate the role of sympathetic neurons in the pathogenesis of T1D. A subsequent validation phase involves examining related soluble biomarkers in blood samples from an independent cohort of T1D patients to corroborate the initial gene expression findings. Results: Gene expression profiles of sympathetic neurons indicate their role in the islet microenvironment in T1D. Using transcriptomic datasets, we identified the upregulation of inflammatory genes, including chemokines, interleukins, and adhesion molecules in T1D patients. These findings were supported by elevated soluble protein levels in blood samples from an independent T1D cohort, providing evidence of the role of sympathetic neurons in the inflammatory state. Pancreatic islet cells showed decreased gene expression for genes linked to insulin synthesis and secretion, glucose metabolism, energy production, and stress responses, indicating impaired pancreatic function in diabetes. Conclusion: Our study opens new avenues for understanding the pathophysiological mechanisms of T1D, showing the role of sympathetic nerves and potential synaptic dysfunction. Thus, the role of sympathetic neurons in regulating insulin within the cellular microenvironment can help identify potential biomarkers for early intervention.
Ananthakumar et al. (Tue,) studied this question.